Intelligence · Clinical Development
Pipeline search results
Programs matching “ixazomib” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 32 pipeline programs matching "ixazomib" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
HM16/047
Takeda
Multiple Myeloma
1 trial -
IXAZOMIB
Takeda
Relapsed or Refractory Systemic Light Chain Amyloidosis
1 trial -
Ixazomib
Takeda
Relapsed Multiple Myeloma
1 trial -
Ixazomib Citrate
Takeda
Multiple Myeloma
2 trials -
MyelomaXIV
Takeda
Multiple Myeloma
1 trial -
IXAZOMIB
Takeda
Follicular Lymphoma
1 trial -
Ixazomib
Takeda
Multiple Myeloma
15 trials -
Ixazomib
Takeda
ALL, Childhood
1 trial -
Ixazomib
Takeda
Leukemia
1 trial -
Ixazomib
Takeda
Mantle Cell Lymphoma
2 trials -
Ixazomib
Takeda
Myeloid Hematologic Malignancy
1 trial -
Ixazomib
Takeda
Newly Diagnosed Multiple Myeloma
1 trial -
Ixazomib
Takeda
Relapsed/Refractory Multiple Myeloma
1 trial -
Ixazomib
Takeda
Smoldering Multiple Myeloma
1 trial -
Ixazomib
Takeda
Triple-Negative Breast Cancer
1 trial -
Ixazomib 1 MG
Takeda
Human Immunodeficiency Virus (HIV)
1 trial -
Ixazomib/Pomalidomide/Dexamethasone
Takeda
Multiple Myeloma
1 trial -
MyDRUG (MMRC-085)
Karyopharm Therapeutics Inc
Relapsed Refractory Multiple Myeloma
1 trial -
ΕΑΕ-2018/ΜΜ03
Takeda
Multiple Myeloma
1 trial -
IXAZOMIB
Takeda
Advanced Non-hematologic Malignancies
1 trial -
IXAZOMIB
Takeda
Advanced Solid Tumors
1 trial -
Ixazomib
Takeda
Lupus Nephritis
1 trial -
Ixazomib
Takeda
Solid Tumors
1 trial -
Ixazomib
Takeda
Relapsed and Refractory Multiple Myeloma
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.